CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

What’s your vision for 2025?

Donate this festive season and join us on our mission to ensure people of all ages can continue to see and connect with the moments and people that matter most.

Video

Watch pioneering ocular gene therapy researcher Professor Jean Bennett deliver an engaging and enlightening presentation on pioneering treatments for blinding retinal disorders for the 15th annual Gerard Crock Lecture.  

Hope in Sight Giving Day

Thanks to your incredible support, we raised $187,607 to advance our research to find new treatments for eye diseases that cause vision loss and blindness. It’s research that could have a life-changing impact for people like Maggie, who lives with low vision from Usher Syndrome.

Consumer involvement

Our new Consumer Program is working alongside people with lived experience to ensure their insights are at the heart of advancing eye research. Learn about the program and meet our Consumer Advisory Group.

Celebrating Cerulea Clinical Trials

Cerulea Clinical Trials, CERA’s new not-for-profit clinical trials centre, is up and running.
Learn how Cerulea will transform the delivery of ophthalmic clinical trials, increase community access to sight-saving therapies and deliver excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.
Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News


Research

21 December 2024

A Centre for Eye Research Australia study has linked low levels of oxygen in the blood overnight – a common sign of obstructive sleep apnoea – with wet age-related macular degeneration.

News

03 December 2024

CERA researchers have explored the potential of genetic analysis to transform how Fuchs’ endothelial corneal dystrophy is diagnosed and treated, with the hope of improving future outcomes for patients.

Research

31 October 2024

Australian scientists have successfully used an innovative gene therapy technique in the lab to combat a key cause of vision loss in ‘wet’ age-related macular degeneration and diabetic eye disease.

Stories

01 November 2024

Melbourne woman Shelley Kline has raised more than $500,000 for research into eye disease as a tribute to the iconic Professor Frank Billson. CERA researchers are among those benefitting from the generous scholarship.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals